Filing Details
- Accession Number:
- 0001209191-14-066728
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-05 17:24:19
- Reporting Period:
- 2014-11-03
- Filing Date:
- 2014-11-05
- Accepted Time:
- 2014-11-05 17:24:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197036 | I Bruce Sachs | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-11-03 | 20,000 | $34.32 | 41,210 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-11-03 | 17,316 | $112.03 | 23,894 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-11-03 | 2,684 | $112.80 | 21,210 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-11-04 | 10,000 | $29.84 | 31,210 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-11-04 | 2,300 | $112.47 | 28,910 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-11-04 | 3,200 | $113.47 | 25,710 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-11-04 | 4,400 | $114.23 | 21,310 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-11-04 | 100 | $115.45 | 21,210 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-11-05 | 100 | $29.84 | 21,310 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-11-05 | 100 | $111.86 | 21,210 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-11-03 | 20,000 | $0.00 | 20,000 | $34.32 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-11-04 | 10,000 | $0.00 | 10,000 | $29.84 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-11-05 | 100 | $0.00 | 100 | $29.84 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-05-31 | No | 4 | M | Direct | |
| 10,000 | 2017-05-31 | No | 4 | M | Direct | |
| 9,900 | 2017-05-31 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.
- Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $112.03 (range $111.64 to $112.63).
- Open market sales reported on this line occurred at a weighted average price of $112.80 (range $112.64 to $113.24).
- Open market sales reported on this line occurred at a weighted average price of $112.47 (range $111.91 to $112.89).
- Open market sales reported on this line occurred at a weighted average price of $113.47 (range $112.91 to $113.88).
- Open market sales reported on this line occurred at a weighted average price of $114.23 (range $113.95 to $114.71).
- Fully vested.
Billionaire Hedge Funds
